Category: Latest News
-
RTX Corp Stock Reaches New Peak at $152.86
RTX Corp’s (NYSE:RTX) shares surged to an unprecedented high of $152.86, marking a notable achievement for the aerospace and defense powerhouse valued at $204 billion. Over the last 12 months, the stock has delivered an impressive 50.45% gain, while the company proudly continues its streak of paying dividends for 55 straight years. This upward momentum…
-
Trump Media Builds $2 Billion Bitcoin Holdings; Shares Rise 8%
Trump Media & Technology Group Corp (NASDAQ:DJT) has amassed $2 billion in bitcoin and related securities, forming a major part of its digital asset expansion strategy. These holdings represent roughly two-thirds of the company’s total liquid assets, estimated at $3 billion. Additionally, Trump Media has allocated about $300 million toward an options acquisition strategy tied…
-
Ollie’s Bargain Outlet Stock Hits Record High at $134.62
Ollie’s Bargain Outlet Holdings Inc (NASDAQ:OLLI) stock soared to a new all-time high of $134.62, pushing the company’s market capitalization to $8.23 billion. The stock has delivered an impressive 20.44% return year-to-date, reflecting strong investor confidence and Ollie’s solid standing in the retail sector. This latest surge underscores the company’s robust performance and momentum, with…
-
General Mills Stock Hits 52-Week Low at $49.61 Amid Market Challenges
General Mills (NYSE:GIS) stock closed at a new 52-week low of $49.61, marking a 23% decline over the past year. Despite the drop, the company continues to offer a solid dividend yield of 4.87% and has maintained dividend payments for 55 consecutive years. The recent decline underscores the ongoing competitive pressures General Mills faces in…
-
Redhill Biopharma Shares Surge 28% After FDA Signals Positive Approval Path for Crohn’s Drug
Redhill Biopharma Ltd (NASDAQ:RDHL) stock soared 28% following encouraging feedback from the U.S. Food and Drug Administration (FDA) on the approval pathway for its RHB-204 program targeting Crohn’s disease. The FDA’s guidance permits Redhill to launch the first clinical trial focusing on a specific subgroup of Crohn’s patients infected with Mycobacterium avium subspecies paratuberculosis (MAP-positive).…
-
Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq
Connect Biopharma Holdings Ltd (NASDAQ:CNTB) saw its stock jump 6.4% after announcing its intention to terminate its American Depositary Receipts (ADR) program and directly list its ordinary shares on the Nasdaq Global Market. The company plans to end its Deposit Agreement with Deutsche Bank Trust Company Americas around September 2, 2025. At that time, all…
-
Bon Natural Life Shares Rise Following $22 Million Distribution Agreement
Bon Natural Life Ltd (NASDAQ:BON) saw its stock climb 4.6% after announcing a new non-exclusive sales distribution deal with Beijing Huahai Keyuan Technology Co. Ltd. The three-year agreement, valued at $22 million, will allow Huahai Keyuan to distribute Bon Natural Life’s natural weight management products across China and Southeast Asia. The product line incorporates a…
-
Lam Research Stock Climbs to 52-Week Peak at $102.32
Lam Research Corp (NASDAQ:LRCX) has reached a new 52-week high, with shares hitting $102.32, marking a significant milestone for the semiconductor equipment giant valued at $130.34 billion. This uptick reflects steady growth and strong investor confidence, as the company’s stock has gained 4.54% over the past year, underscoring its robust market position. Lam Research has…
-
Autonomix Medical Shares Jump 13% Following Smart Torquer Patent Approval
Autonomix Medical Inc (NASDAQ:AMIX) saw its stock climb 13% after the medical device firm announced it received a patent from the U.S. Patent and Trademark Office for its innovative “Smart Torquer” technology. The newly granted patent (No. 12,295,646) protects a smart torquer device engineered to improve the handling of intravascular instruments during minimally invasive procedures,…
-
Bit Origin Shares Rally 12% Following Strategic Acquisition of 40.5 Million Dogecoin
Shares of Bit Origin Ltd (NASDAQ:BTOG) surged 12% after the company revealed its initial strategic purchase of approximately 40.5 million Dogecoin (DOGE) as part of a broader digital asset treasury plan. This acquisition marks the first step in Bit Origin’s previously announced capital facility program, which allows for investments up to $500 million. The company…